The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

Lignende værker

• The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial
  af: van Londen, G. J., et al.
  Udgivet: (2009)
• Prevention of Bone Loss with Risedronate in Breast Cancer Survivors: A Randomized, Controlled Clinical Trial
  af: Greenspan, Susan L., et al.
  Udgivet: (2015)
• Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
  af: Greenspan, Susan L., et al.
  Udgivet: (2008)
• The Effect of Exercise on Body Composition and Bone Mineral Density in Breast Cancer Survivors taking Aromatase Inhibitors
  af: Thomas, Gwendolyn A., et al.
  Udgivet: (2016)
• Aromatase, Aromatase Inhibitors, and Breast Cancer
  af: Chumsri, Saranya, et al.
  Udgivet: (2011)